Indication
Retinal Detachment
12 clinical trials
17 products
1 drug
Product
MydriacylClinical trial
A Single Centre, Controlled, Investigation to Evaluate the Performance of the Hyperspectral Camera for Retinal Non-invasive Examination Through the Observation of Retinal OxygenationStatus: , Estimated PCD: 2023-11-01
Clinical trial
Amniotic Membrane Visio-AMTRIX in Recurrent Macular HoleStatus: Terminated, Estimated PCD: 2022-10-10
Product
Visio-AMTRIXClinical trial
Treatment of Proliferative Vitreoretinopathy With Intravitreal InfliximabStatus: Completed, Estimated PCD: 2023-11-10
Product
InfliximabClinical trial
Evaluation of 5-fluorouracil and Low Molecular Weight Heparin Intraoperative Infusion in Preventing Proliferative Vitreoretinopathy in High Risk Pediatric Rhegmatogenous Retinal DetachmentStatus: Completed, Estimated PCD: 2022-10-21
Product
PlaceboClinical trial
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Primary Rhegmatogenous Detachments and Retinal Detachment Due to Proliferative Vitreoretinopathy or Open-Globe Injury: A Phase I/II Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-09-01
Product
NetarsudilClinical trial
Comparison of Two High-Density Silicone Oils in Complicated Rhegmatogenous Retinal DetachmentStatus: Withdrawn, Estimated PCD: 2006-08-01
Product
Oxane HDProduct
DensironProduct
Triamcinolone AcetonideProduct
MoxifloxacinProduct
PrednisoloneProduct
AtropineClinical trial
Assessing the Efficacy and Safety of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert, When Placed Within the Lower Eye Lid Canaliculus in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal DetachmentStatus: Terminated, Estimated PCD: 2023-01-25
Product
DextenzaClinical trial
A Multi-Center, Randomized, Double-Blind, Placebo Controlled, Study on the Use of Rho-Kinase Inhibitor to Reduce Ore Prevent Proliferative Vitreoretinopathy (PVR) in Eyes With Rhegmatogenous Retinal Detachment (RRD) at High Risk of PVRStatus: Recruiting, Estimated PCD: 2023-12-31
Product
Glycerin/Hypromellose/PegClinical trial
Using Intraoperative Triamcinolone Acetonide Irrigation to Reduce Post-Operative Pain From Scleral Buckle SurgeryStatus: Completed, Estimated PCD: 2022-10-20
Clinical trial
Intra-ocular Penetration of Oral Lamivudine and Measurement of Systemic Inflammatory Markers in Patients Undergoing Rhegmatogenous Retinal Detachment SurgeryStatus: Recruiting, Estimated PCD: 2024-08-01
Product
LamivudineDrug
VarlilumabClinical trial
The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative VitreoretinopathyStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Product
Topotecan